Cargando…

(E)-3-(2-{2-[1-(3-Hy­droxy­phen­yl)ethyl­idene]hydrazin­yl}-1,3-thia­zol-4-yl)-2H-chromen-2-one

In the title compound, C(20)H(15)N(3)O(3)S, the thia­zole ring is approximately planar, with a maximum deviation of 0.003 (1) Å, and makes dihedral angles of 7.44 (6) and 1.88 (6)° with the hy­droxy-substituted phenyl ring and the pyran ring, respectively. The hydroxyl group is disordered over two s...

Descripción completa

Detalles Bibliográficos
Autores principales: Arshad, Afsheen, Osman, Hasnah, Lam, Chan Kit, Hemamalini, Madhukar, Fun, Hoong-Kun
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089171/
https://www.ncbi.nlm.nih.gov/pubmed/21754396
http://dx.doi.org/10.1107/S1600536811012189
_version_ 1782202994458099712
author Arshad, Afsheen
Osman, Hasnah
Lam, Chan Kit
Hemamalini, Madhukar
Fun, Hoong-Kun
author_facet Arshad, Afsheen
Osman, Hasnah
Lam, Chan Kit
Hemamalini, Madhukar
Fun, Hoong-Kun
author_sort Arshad, Afsheen
collection PubMed
description In the title compound, C(20)H(15)N(3)O(3)S, the thia­zole ring is approximately planar, with a maximum deviation of 0.003 (1) Å, and makes dihedral angles of 7.44 (6) and 1.88 (6)° with the hy­droxy-substituted phenyl ring and the pyran ring, respectively. The hydroxyl group is disordered over two sets of sites, with an occupancy ratio of 0.567 (3):0.433 (3). In the crystal, the major disorder component mol­ecules are connected via bifurcated (three-centre) O—H⋯O and C—H⋯O hydrogen bonds, generating R (1) (2)(6) motifs and resulting in supra­molecular chains along the a axis. In the minor occupancy component, however, mol­ecules are connected via C—H⋯O hydrogen bonds, forming supra­molecular chains along the b axis. Furthermore, the crystal structure is stabilized by π–π inter­actions between the thia­zole rings [centroid–centroid distance = 3.5476 (7) Å].
format Text
id pubmed-3089171
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-30891712011-07-13 (E)-3-(2-{2-[1-(3-Hy­droxy­phen­yl)ethyl­idene]hydrazin­yl}-1,3-thia­zol-4-yl)-2H-chromen-2-one Arshad, Afsheen Osman, Hasnah Lam, Chan Kit Hemamalini, Madhukar Fun, Hoong-Kun Acta Crystallogr Sect E Struct Rep Online Organic Papers In the title compound, C(20)H(15)N(3)O(3)S, the thia­zole ring is approximately planar, with a maximum deviation of 0.003 (1) Å, and makes dihedral angles of 7.44 (6) and 1.88 (6)° with the hy­droxy-substituted phenyl ring and the pyran ring, respectively. The hydroxyl group is disordered over two sets of sites, with an occupancy ratio of 0.567 (3):0.433 (3). In the crystal, the major disorder component mol­ecules are connected via bifurcated (three-centre) O—H⋯O and C—H⋯O hydrogen bonds, generating R (1) (2)(6) motifs and resulting in supra­molecular chains along the a axis. In the minor occupancy component, however, mol­ecules are connected via C—H⋯O hydrogen bonds, forming supra­molecular chains along the b axis. Furthermore, the crystal structure is stabilized by π–π inter­actions between the thia­zole rings [centroid–centroid distance = 3.5476 (7) Å]. International Union of Crystallography 2011-04-07 /pmc/articles/PMC3089171/ /pubmed/21754396 http://dx.doi.org/10.1107/S1600536811012189 Text en © Arshad et al. 2011 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Organic Papers
Arshad, Afsheen
Osman, Hasnah
Lam, Chan Kit
Hemamalini, Madhukar
Fun, Hoong-Kun
(E)-3-(2-{2-[1-(3-Hy­droxy­phen­yl)ethyl­idene]hydrazin­yl}-1,3-thia­zol-4-yl)-2H-chromen-2-one
title (E)-3-(2-{2-[1-(3-Hy­droxy­phen­yl)ethyl­idene]hydrazin­yl}-1,3-thia­zol-4-yl)-2H-chromen-2-one
title_full (E)-3-(2-{2-[1-(3-Hy­droxy­phen­yl)ethyl­idene]hydrazin­yl}-1,3-thia­zol-4-yl)-2H-chromen-2-one
title_fullStr (E)-3-(2-{2-[1-(3-Hy­droxy­phen­yl)ethyl­idene]hydrazin­yl}-1,3-thia­zol-4-yl)-2H-chromen-2-one
title_full_unstemmed (E)-3-(2-{2-[1-(3-Hy­droxy­phen­yl)ethyl­idene]hydrazin­yl}-1,3-thia­zol-4-yl)-2H-chromen-2-one
title_short (E)-3-(2-{2-[1-(3-Hy­droxy­phen­yl)ethyl­idene]hydrazin­yl}-1,3-thia­zol-4-yl)-2H-chromen-2-one
title_sort (e)-3-(2-{2-[1-(3-hy­droxy­phen­yl)ethyl­idene]hydrazin­yl}-1,3-thia­zol-4-yl)-2h-chromen-2-one
topic Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089171/
https://www.ncbi.nlm.nih.gov/pubmed/21754396
http://dx.doi.org/10.1107/S1600536811012189
work_keys_str_mv AT arshadafsheen e32213hydroxyphenylethylidenehydrazinyl13thiazol4yl2hchromen2one
AT osmanhasnah e32213hydroxyphenylethylidenehydrazinyl13thiazol4yl2hchromen2one
AT lamchankit e32213hydroxyphenylethylidenehydrazinyl13thiazol4yl2hchromen2one
AT hemamalinimadhukar e32213hydroxyphenylethylidenehydrazinyl13thiazol4yl2hchromen2one
AT funhoongkun e32213hydroxyphenylethylidenehydrazinyl13thiazol4yl2hchromen2one